Cruz Senior Trial Starts with Supraflex Cruz in Europe
Business Wire India Release summary Study to enrol patients between the age of 80 and 90 years Study aims to evaluate ultra-thin biodegradable polymer Supraflex Cruz Sirolimus-eluting Coronary Stent System…